Long-term Effects of Endobronchial Valve Implantation on Cardiac Function and Skeletal Muscle Function

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 22 to 100 Show 5 more changesShow less
    • Primary completion date: Dec 31, 2024 to Dec 31, 2028
    • Sponsor refiled this as recruiting (was completed)
    • Study completion date: Dec 31, 2024 to Dec 31, 2029
    • Eligibility criteria expanded, about 14 words
    • Site details revised
  2. Trial status: Recruiting to Completed
    • Enrollment target: estimated 40 to confirmed 22
    • Site details revised
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this type of study: clinical trial is to evaluate the effect of bronchial valve implantation on cardiac function and skeletal muscle function in Chronic Obstructive Pulmonary Disease. The main question it aims to answer are:evaluate the effect of bronchial valve implantation on cardiac function and skeletal muscle function. Participants will undergo Lung volume reduction surgery with endobronchial valve implantation.
Trial Details
NCT Number NCT05775588
Lead Sponsor China-Japan Friendship Hospital
Conditions
(from sponsor)		 Chronic Obstructive Pulmonary Disease
Related terms Pulmonary Disease, Chronic Obstructive
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov